{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T16:13:56Z","timestamp":1777824836857,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.intimp.2021.107770","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T05:30:52Z","timestamp":1621402252000},"page":"107770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Advances in regulatory B cells in autoimmune thyroid diseases"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-7164","authenticated-orcid":false,"given":"Shaoyang","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junning","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-3231","authenticated-orcid":false,"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2021.107770_b0005","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4049\/jimmunol.113.6.1716","article-title":"Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity[J]","volume":"113","author":"Neta","year":"1974","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107770_b0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation[J]","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2021.107770_b0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function[J]","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.107770_b0020","doi-asserted-by":"crossref","unstructured":"K. Miles, J. Heaney, Z. Sibinska, et al., A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells[J], in: Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(3): 887\u2013892.","DOI":"10.1073\/pnas.1109173109"},{"key":"10.1016\/j.intimp.2021.107770_b0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.coi.2011.10.007","article-title":"B cells and autoimmunity[J]","volume":"23","author":"Pillai","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107770_b0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells[J]","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2021.107770_b0035","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis[J]","volume":"178","author":"Evans","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107770_b0040","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","article-title":"Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice[J]","volume":"182","author":"Blair","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107770_b0045","doi-asserted-by":"crossref","unstructured":"M. Gray, K. Miles, D. Salter, et al., Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells[J], Proceedings of the National Academy of Sciences of the United States of America, 2007;104(35):14080\u201314085.","DOI":"10.1073\/pnas.0700326104"},{"issue":"4","key":"10.1016\/j.intimp.2021.107770_b0050","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4049\/jimmunol.170.4.1707","article-title":"B cell developmental requirement for the G\u03b1i2 gene[J]","volume":"170","author":"Dalwadi","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107770_b0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses[J]","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation[J]","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer[J]","volume":"1183","author":"Dilillo","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients[J]","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2021.107770_b0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10\u2013competent B-cell subset in humans that parallels mouse regulatory B10 cells[J]","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12134","article-title":"Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells[J]","volume":"7","author":"Korniotis","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2021.107770_b0085","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","article-title":"Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells[J]","volume":"186","author":"Carter","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2021.107770_b0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aas9944","article-title":"BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance[J]","volume":"4","author":"Matsushita","year":"2018","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.intimp.2021.107770_b0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MED.0b013e328355461b","article-title":"A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus[J]","volume":"19","author":"Giannoukakis","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"173","key":"10.1016\/j.intimp.2021.107770_b0100","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation[J]","volume":"5","author":"Floresborja","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens[J]","volume":"133","author":"Akdis","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2021.107770_b0110","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD[J]","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0451-6","article-title":"Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1 + regulatory B cell expansion[J]","volume":"6","author":"Ye","year":"2018","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.intimp.2021.107770_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000324442","article-title":"Why is the thyroid so prone to autoimmune disease?","volume":"75","author":"Saranac","year":"2011","journal-title":"Horm Res Paediatr."},{"issue":"5","key":"10.1016\/j.intimp.2021.107770_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127949","article-title":"Characterization of regulatory B cells in Graves\u2019 disease and Hashimoto\u2019s thyroiditis[J]","volume":"10","author":"Kristensen","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B Cells[J]","volume":"30","author":"Mauri","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2021.107770_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049835","article-title":"Decrease in proportion of CD19+CD24hiCD27+ B cells and impairment of their suppressive function in Graves\u2019 disease[J]","volume":"7","author":"Zha","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/08916934.2019.1697690","article-title":"Lower proportion of CD19+IL-10+ and CD19+CD24+CD27+ but not CD1d+CD5+CD19+CD24+CD27+ IL-10+ B cells in children with autoimmune thyroid diseases[J]","volume":"53","author":"Stozek","year":"2020","journal-title":"Autoimmunity"},{"issue":"9","key":"10.1016\/j.intimp.2021.107770_b0145","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1210\/jc.2018-01812","article-title":"Defective regulatory B cells are associated with thyroid-associated ophthalmopathy[J]","volume":"104","author":"Chen","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"11","key":"10.1016\/j.intimp.2021.107770_b0150","first-page":"1190","article-title":"Abnormal proportions of immune regulatory cells and their subsets in peripheral blood of patients with Graves' disease[J]","volume":"30","author":"He","year":"2014","journal-title":"Chinese J. Cellular Mol. Immunol."},{"issue":"03","key":"10.1016\/j.intimp.2021.107770_b0155","first-page":"246","article-title":"The expression changes of regulatory B cells in the pathogenesis of Graves disease mouse model[J]. Chinese","volume":"28","author":"Bi","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107770_b0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/08916934.2019.1698553","article-title":"Low frequency of IL-10-producing B cells and high density of ILC2s contribute to the pathological process in Graves' disease, which may be related to elevated-TRAb levels[J]","volume":"53","author":"Ji","year":"2020","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2021.107770_b0165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biocel.2017.08.002","article-title":"Dysfunction of CD24+CD38+ B cells in patients with Hashimoto\u2019s thyroiditis is associated with a lack of interleukin 10[J]","author":"Yu","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2021.107770_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5290865","article-title":"Breg cells in celiac disease isolated or associated to Hashimoto\u2019s thyroiditis[J]","author":"Santaguida","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.intimp.2021.107770_b0175","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.4049\/jimmunol.0801859","article-title":"Novel human transitional B cell populations revealed by B cell depletion therapy[J]","volume":"182","author":"Palanichamy","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107770_b0180","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1210\/jc.2013-3469","article-title":"The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1\/TH2) involved in thyroid autoimmune disorders[J]","volume":"99","author":"Marique","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2012.07.004","article-title":"B-cell exposure to self-antigen induces IL-10 producing B cells as well as IL-6- and TNF-\u03b1-producing B-cell subsets in healthy humans[J]","volume":"145","author":"Langkjaer","year":"2012","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107770_b0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation[J]","volume":"140","author":"Carl","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.intimp.2021.107770_b0195","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation[J]","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.107770_b0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000452541","article-title":"Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases[J]","volume":"40","author":"Li","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2021.107770_b0205","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in graves\u2019 Disease[J]","volume":"186","author":"Mao","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107770_b0210","article-title":"Regulatory B cells: TIM transplant tolerance, and rejection[J]","volume":"6","author":"Cherukuri","year":"2021","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ajt.15546","article-title":"Antigen-dependent interactions between regulatory B cells and T cells at the T: B border inhibit subsequent T cell interactions with DCs[J]","volume":"20","author":"Mohib","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.intimp.2021.107770_b0220","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1172\/JCI46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice[J]","volume":"121","author":"Ding","year":"2011","journal-title":"J. Clin. Investigat."},{"issue":"7492","key":"10.1016\/j.intimp.2021.107770_b0225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases[J]","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107770_b0230","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3389\/fimmu.2020.01051","article-title":"Interleukin 35-producing exosomes suppress neuroinflammation and autoimmune Uveitis[J]","volume":"11","author":"Kang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107770_b0235","first-page":"2359","article-title":"Decreased serum levels of IL-27and IL-35 in patients with Graves disease[J]","author":"Saeed","year":"2020","journal-title":"Arch Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.intimp.2021.107770_b0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","article-title":"Lipid-antigen presentation by CD1d+ B cells is essential for the maintenance of invariant natural killer T cells[J]","volume":"36","author":"Bosma","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2021.107770_b0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus[J]","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2021.107770_b0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000078438","article-title":"TH1 AND TH2 SERUM CYTOKINE PROFILES CHARACTERIZE PATIENTS WITH HASHIMOTO'S THYROIDITIS (TH1) AND GRAVES' DISEASE (TH2)[J]","volume":"11","author":"Phenekos","year":"2004","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000135626","article-title":"Immune-endocrine interactions in autoimmune thyroid diseases[J]","volume":"15","author":"Klecha","year":"2008","journal-title":"NeuroImmunoModulation"},{"issue":"3","key":"10.1016\/j.intimp.2021.107770_b0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.20945\/2359-3997000000244","article-title":"Intrathyroid injection of dexamethasone inhibits Th2 cells in Graves' disease[J]","volume":"64","author":"He","year":"2020","journal-title":"Arch. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107770_b0265","article-title":"The Th1 chemokine MIG in Graves\u2019 Disease: a narrative review of the literature[J]","volume":"170","author":"Giusti","year":"2019","journal-title":"Clin. Ter."},{"issue":"8","key":"10.1016\/j.intimp.2021.107770_b0270","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1507\/endocrj.EJ18-0050","article-title":"Association of the polymorphisms in Th2 chemotaxis-related genes with the development and prognosis of autoimmune thyroid diseases[J]","volume":"65","author":"Omori","year":"2018","journal-title":"Endocr. J."},{"key":"10.1016\/j.intimp.2021.107770_b0275","doi-asserted-by":"crossref","DOI":"10.1111\/iji.12472","article-title":"Association of cytokine Th2 gene polymorphisms with autoimmune thyroid diseases in Tunisian population[J]","author":"Mestiri","year":"2020","journal-title":"Int. J. Immunogenet."},{"issue":"48","key":"10.1016\/j.intimp.2021.107770_b0280","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.3748\/wjg.v26.i48.7593","article-title":"Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells[J]","volume":"26","author":"Sun","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2021.107770_b0285","article-title":"Interleukin-10 production by B cells is regulated by cytokines, but independently of GATA-3 or FoxP3 expression[J]","volume":"347","author":"Bohacova","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2021.107770_b0290","article-title":"A promising mouse model of graves' orbitopathy induced by adenovirus expressing thyrotropin receptor A subunit[J]","author":"Zhang","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.intimp.2021.107770_b0295","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/609593","article-title":"Th1, Th2, and th17 cytokine involvement in thyroid associated ophthalmopathy[J]","author":"Shen","year":"2015","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.intimp.2021.107770_b0300","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10\u2013producing B cells[J]","volume":"197","author":"Mauri","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.107770_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.03093","article-title":"Bacterial immunogenicity is critical for the induction of regulatory B cells in suppressing inflammatory immune responses[J]","author":"Maerz","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107770_b0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy[J]","volume":"16","author":"Taylor","year":"2020","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/j.intimp.2021.107770_b0315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2015.03.016","article-title":"The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy[J]","author":"Quan","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"9419","key":"10.1016\/j.intimp.2021.107770_b0320","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells[J]","volume":"363","author":"Blanc","year":"2004","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.intimp.2021.107770_b0325","article-title":"Effects of umbilical cord mesenchymal stem cell transplantation on regulatory B cells in mice with Graves disease[J]","volume":"44","author":"Li","year":"2015","journal-title":"Chongqing Med. J."},{"issue":"5","key":"10.1016\/j.intimp.2021.107770_b0330","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000351450","article-title":"Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis[J]","volume":"20","author":"Guo","year":"2013","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"10.1016\/j.intimp.2021.107770_b0335","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13287-016-0376-2","article-title":"Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells[J]","volume":"7","author":"Chao","year":"2016","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2021.107770_b0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/enr-2016-0009","article-title":"Role of interlekin-35 as a biomarker in patients with newly diagnosed Hashimoto's thyroiditis[J]","volume":"50","author":"Yilmaz","year":"2016","journal-title":"Endocrine Regulations"},{"issue":"5","key":"10.1016\/j.intimp.2021.107770_b0345","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/08916930701463485","article-title":"Lack of effect of methimazole on dendritic cell (DC) function and DC-induced Graves' hyperthyroidism in mice[J]","volume":"40","author":"Mizutori","year":"2007","journal-title":"Autoimmunity"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921004069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921004069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:07:30Z","timestamp":1727291250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921004069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":69,"alternative-id":["S1567576921004069"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107770","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in regulatory B cells in autoimmune thyroid diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107770"}}